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Abstract 
Background: The diagnosis of active Toxocara canis infections in humans is challenging. Larval stages of T. canis do 
not replicate in human tissues and disease may result from infection with a single T. canis larva. Recently, we devel‑
oped a nanobody‑based electrochemical magnetosensor assay with superior sensitivity to detect T. canis excretory‑
secretory (TES) antigens. Here, we evaluate the performance of the assay in children from an Ecuadorian birth cohort 
that followed children to five years of age.
Methods: Samples were selected based on the presence of peripheral blood eosinophilia and relative eosinophil 
counts. The samples were analyzed by the nanobody‑based electrochemical magnetosensor assay, which utilizes a 
bivalent biotinylated nanobody as capturing agent on the surface of streptavidin pre‑coated paramagnetic beads. 
Detection was performed by a different nanobody chemically labelled with horseradish peroxidase.
Results: Of 87 samples tested, 33 (38%) scored positive for TES antigen recognition by the electrochemical magne‑
tosensor assay. The average concentration of TES antigen in serum was 2.1 ng/ml (SD = 1.1). The positive result in the 
electrochemical assay was associated with eosinophilia > 19% (P = 0.001). Parasitological data were available for 57 
samples. There was no significant association between positivity by the electrochemical assay and the presence of 
other soil‑transmitted helminth infections.
Conclusions: Our nanobody‑based electrochemical assay provides highly sensitive quantification of TES antigens in 
serum and has potential as a valuable tool for the diagnosis of active human toxocariasis.
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Background
Human toxocariasis (HT) is an infection caused primarily 
by the roundworm Toxocara canis and to a lesser extent 
by T. cati [1]. It is a zoonosis with a worldwide distribu-
tion including temperate regions, although greater preva-
lence rates are observed in tropical areas [2–4]. Human 
infection occurs after the accidental ingestion of food or 
soil contaminated with eggs of the parasite. The larvae 
migrate to the lungs, liver, eyes and central nervous sys-
tem of the host causing two disease variants: a compart-
mentalized form represented by ocular larvae migrans 
(OLM) and neurotoxocariasis [5], and a disseminated 
form represented by visceral larvae migrans (VLM), 
resulting from massive ingestion of embryonated eggs, 
and covert toxocariasis (CT) that is far more frequent 
than the other forms [5–7]. All the forms of the disease 
are frequently accompanied by eosinophilia [8].
Currently, the laboratory diagnosis of the disease is 
based on the detection of IgG antibodies (Ab) against 
the T. canis excretory-secretory (TES) antigens, a mix 
of highly glycosylated proteins released by migratory 
larvae into the tissues [9]. Limitations of the TES-based 
antibody detection (TES-Ab) ELISAs are low specificity 
[10, 11] and the inability to distinguish current from past 
infections. Anti-TES immunoglobulins may remain in 
the circulation for years after infection [12], limiting the 
usefulness of the test for monitoring response to treat-
ment or the occurrence of active infections at a popula-
tion level. Eosinophil counts in peripheral blood are often 
used to aid in the diagnosis of HT [1, 13, 14]. However, 
eosinophilia is associated with other helminth parasite 
infections or may be absent in active HT [8]. The hetero-
geneous clinical representation of the disease, combined 
with the lack of highly specific and sensitive diagnostic 
tools, makes the diagnosis of HT very challenging.
The detection of TES antigens has been proposed as an 
alternative to TES-Ab ELISAs with limited success to date 
[15–18]. Larval stages of T. canis release TES antigens 
into host tissues of which only a small fraction reaches the 
systemic circulation. Mouse models indicate that after the 
ingestion of 50 eggs, TES antigen is detectable in the cir-
culation three days post-infection while anti-TES antibod-
ies appear after three weeks [19]. This indicates a limited 
time during the course of the infection when TES antigens 
are not complexed with immunoglobulins.
Recently, we developed a diagnostic system based on 
single domain antigen-binding fragments (nanobodies, 
Nbs) from camel heavy-chain antibodies with a highly 
sensitive electrochemical readout. This system employs 
Nbs as specific TES antigen binders, which were able to 
detect TES in serum from mice infected with T. canis 
eggs. Due to their small size, Nbs are able to recognize 
cryptic epitopes on their cognate antigen [20]. This 
approach has been demonstrated to provide high speci-
ficity with no cross-reactivity with antigens of other hel-
minths [21, 22] and a sensitivity in the low picogram 
range [22]. Here, we evaluate the performance of the 
electrochemical magnetosensor assay in samples of chil-
dren in an Ecuadorian birth cohort [23]. We investigated 
the association of positivity for TES antigen recognition 
in the Nb-based electrochemical assay with peripheral 
blood eosinophilia, and with positive Toxocara serology 
(as assessed by TES-Ab ELISA). Additionally, we evalu-
ated potential cross-reactivity of the electrochemical 
assay in samples from children infected with other soil-
transmitted helminth (STH) infections.
Methods
Production of TES antigens
TES was produced as described by de Savigny [24]. The 
final material was dialyzed in phosphate-buffered saline 
(PBS) pH 7.4 and lyophilized in separate batches accord-
ing to the source larvae. The antigens were reconstituted 
in Milli-Q water and the concentration was estimated 
in triplicate by UV spectrophotometry (Nanodrop), 
 (OD280nm of 1 corresponds to 1 mg/ml).
Construction of the immune library and Nbs selection
Detailed protocols for library construction and Nbs 
selection are available elsewhere [20, 25]. In vivo bioti-
nylated nanobodies 2TCE49 and monovalent nanobodies 
1TCE39 [21] chemically coupled to horseradish peroxi-
dase were used as reagents to capture TES.
Serum immunocomplex dissociation (ICD)
Serum samples were subjected to immune complex dis-
sociation (ICD) to dissociate possible endogenous anti-
bodies that can potentially block the Nb binding sites 
of TES antigens [18]. Briefly, 250 µl of serum was mixed 
with 250 µl of 100% glycerol and thoroughly vortexed. 
The mixture was diluted in 500 µl of 1.0 M ethylenedi-
aminetetraacetic acid (EDTA) (pH 8) and heated in boil-
ing water for 10 min. The samples were immediately 
centrifuged at maximum speed (19000×g) for 10 min and 
the supernatant was collected for further analysis.
Electrochemical assay
The electrochemical assay was performed according to a 
protocol developed by our group [22]. The assay was per-
formed on the surface of streptavidin pre-coated magnetic 
beads (50 µg/sample) (Dynabeads™ M-280; Thermo Fisher 
Scientific, Waltham, USA). After each step the beads were 
collected in a magnetic rack for 2 min and washed 3 times. 
First, we covered the beads with bivalent biotinylated Nbs 
2TCE49 (2 µg/ml) in PBS Tween 20 0.05% (PBS-T20) to 
obtain a coverage of 2 µg of Nbs per mg of beads. Then, 
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100 µl of the supernatant from the immunocomplex disso-
ciation was added to the beads together with Nb 1TCE39 
coupled to HRP at a final concentration of 10 ng/ml. The 
samples were incubated at room temperature for 15 min 
in agitation. After that, the supernatant was discarded 
and each sample was diluted in 15 µl of 0.5 mM citrate-
acetate buffer (35 mM sodium acetate, 50 mM citric acid, 
pH 5.0), and injected in 60 µl of reading buffer [(0.5 mM 
of 3,3’,5,5’-Tetramethylbenzidine (TMB), 2 mM  H2O2 
diluted in 0.5 mM citrate buffer)] placed on the surface 
of a screen-printed electrode (SPE; Metrohm DropSens, 
Oviedo, Spain). A neodymium magnet was attached to the 
underside of the electrode for accumulating the signal of 
the reaction. The readout of the reaction was performed 
via amperometry. The electrode was connected to a poten-
tiostat EmStat Blue (PalmSens, Houten, The Netherlands) 
and the reaction was registered for 180 s with a potential 
of 0.0 V. The average of the last 20 s was calculated. Nega-
tive AB male human serum extracted from plasma (Sigma-
Aldrich, St. Louis, USA) and subjected to exactly the same 
protocol of immunocomplex dissociation was used as a 
negative control. The limit of detection of the assay (LOD) 
was calculated as the average of at least five blanks. A 
standard curve was constructed in negative serum (Sigma-
Aldrich) spiked with TES in 10-fold dilutions and treated 
with the ICD protocol. Additionally, we constructed a 
standard curve in PBS-T20 spiked with TES. Extrapolation 
of the concentration of TES in serum was performed using 
a linear model and taking into consideration sample dilu-
tion after ICD. Samples were run in duplicate.
TES‑Ab ELISA
To detect specific anti-TES IgG in ELISA (TES Ab-
ELISA), we used a commercial ELISA for the diagnosis 
of human toxocariasis (Bordier Affinity, Crissier, Swit-
zerland), according to the manufacturer’s instructions. 
The reaction was read in an ELISA spectrophotometer 
equipped with a filter for the 405 nm wavelength. All 
samples were run in duplicate.
Patients and samples
A total of 87 plasma samples from the ECUAVIDA birth 
cohort were used in this analysis. The ECUAVIDA birth 
cohort study was designed to study the effects of early life 
exposure to STH parasites on the development of allergy 
[23]. The study was performed in the tropical rural dis-
trict of Quinindé, Esmeraldas Province, Ecuador. Stool 
and serum samples were collected between 2007 and 
2012 when the children reached 13, 24 and 36 months of 
age. One study group consisted of 22 samples from chil-
dren with eosinophilia < 20% of total white blood count 
(WBC): 11 samples from children aged 13 months and 
11 samples from children aged 24 months. The second 
group consisted of 65 samples from children with eosino-
philia > 19% of total WBC: 7 samples from children aged 
13 months, 18 samples from children aged 24 months 
and 40 samples from children aged 36 months.
Clinical and laboratory data
Children were followed up routinely at 13, 24 and 36 
months of age; a complete clinical evaluation was car-
ried out by a study physician, a blood and stool sample 
were collected, and a questionnaire was administered to 
the child’s mother to collect information on any health 
problems during the previous 12 months. Whole blood 
and differential counts were estimated using venous 
blood following standard laboratory procedures [23] and 
plasma was separated by centrifugation (19000×g) and 
stored at − 30  °C until use. Stool samples were exam-
ined using a combination of microscopic methods that 
were conducted on all samples with sufficient quantity: 
direct saline smear; modified kato-katz (quantification 
of soil-transmitted helminth eggs); and formol-ethyl ace-
tate concentration methods. The detailed parasitologi-
cal procedures for stool analysis are available elsewhere 
[26]. Modified kato-katz and concentration methods 
were performed on duplicate slides. A stool sample was 
considered positive if STH helminth eggs or larvae were 
detected by at least one of the three methods.
Data analysis
Chi-square test was used to determine if there was an 
association (i) between positivity in the TES-Ab ELISA 
and eosinophilia groups (> 19% and < 20%), and (ii) 
between positivity in the electrochemical assay and posi-
tivity in the TES-Ab ELISA in either group of eosino-
philia (> 19% and < 20%). Fisher’s exact test was used to 
determine if there was an association (i) between positiv-
ity in the electrochemical assay and eosinophilia groups 
(> 19% and < 20%); (ii) between the presence of helminths 
and positivity in the electrochemical assay; and (iii) 
between the presence of helminths and positivity in the 
TES-Ab ELISA. Results were considered significant when 
the P-value was < 0.05. All data were entered into Excel, 
and SPSS version 15.0 and Prisma GraphPad 8.0. were 
used for statistical analysis.
Results
Electrochemical assay
Standard curves in serum and PBS-T20 spiked with TES 
antigen and subjected to immunocomplex dissocia-
tion (ICD) antigen showed a LOD of 0.01 ng/ml and 0.9 
ng/ml, respectively (Fig.  1). In total, 38% (33/87) of the 
serum samples were positive in the electrochemical assay 
(Fig. 2). The average concentration of TES antigen in the 
serum of positive samples was 2.1 ng/ml (SD = 1.1).
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Role of eosinophilia in T. canis infections
Out of 87 samples, 38% (33/87) were positive by electro-
chemical analysis and 67% (58/87) by TES-Ab ELISA. 
Only 9% (2/22) of the samples from the group with eosin-
ophilia < 20% were positive with the electrochemical 
assay, while 48% (31/65) were positive in the group with 
eosinophilia > 19% (Fig.  3a). For TES-Ab ELISA, these 
percentages were 41% (9/22) and 75% (49/65), respec-
tively (Fig.  3b). Eosinophilia was significantly associated 
with positivity in the electrochemical assay (OR: 9.12, 
95% CI: 2.20–41.25, P = 0.001) as well as in the TES-Ab 
ELISA (χ2 = 8.79, df  = 1, P = 0.003). In the group with 
eosinophilia > 19%, 50% (24/48) of the samples were posi-
tive in the TES-Ab ELISA and electrochemistry, while 
other 50% (24/48) were positive in the TES-Ab ELISA 
and negative in electrochemistry. In the group with 
eosinophilia < 20%, we found that only 11% (1/9) were 
positive in the TES-Ab ELISA and electrochemistry, and 
89% (8/9) were positive in the TES-Ab ELISA and nega-
tive in electrochemistry. No significant association was 
found between electrochemical assay and TES-Ab ELISA 
positivity in either of the group of eosinophilia > 19% 
Fig. 1 TES detection standard curves. a PBS‑T20 spiked with TES. b Serum spiked with TES after ICD
Fig. 2 Plot of the full dataset showing the amperometric reading and the equivalent concentrations of TES antigen. The blue dotted line represents 
the blank of the assay (estimated as the average of 6 different reactions in negative serum without TES and subjected to ICD). Red dotted line is the 
LOD of the assay, 0.9 ng/ml. The variation in each point represents the absolute reading number of each measurement. Only the measurements 
that were higher than the LOD in both measurements were considered as positive
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(χ2 = 1.09, df  = 1, P = 0.26) or < 20% (OR: 1.5, 95% CI: 
0.16–12.71, P > 0.99).
Cross‑reactivity with other helminth parasites
Parasitological data were available for 57 samples. Hel-
minth infections were found in 19% (4/19) of the sam-
ples that scored positive in electrochemistry (Fig.  4a). 
Two were positive for A. lumbricoides and two for Tri-
churis trichiura. Of the samples that scored negative 
in electrochemistry, 45% (17/38) were positive for the 
presence of helminths. For TES-Ab ELISA (Fig.  4b), 
these percentages were 44% (16/36) for A. lumbricoides 
and 24% (5/21) for T. trichiura. There was no significant 
association between helminth infections and positive 
outcomes in the electrochemical assay (OR = 0.33, 95% 
CI = 0.11–1.18, P = 0.14) or TES-Ab ELISA (OR = 2.56, 
95% CI = 0.79–7.68, P = 0.16). The distribution of hel-




In the past, several attempts to detect TES antigen in 
clinical samples have been performed with limited suc-
cess. A two-site antigen ELISA with the monoclonal anti-
body Tcn-2 was the first attempt to identify active HT 
infections [15, 26]. This assay had a LOD of 20 ng/ml and 
a sensitivity of 68, 10 and 29% in VLM, inactive infec-
tions (patients that were positive in TES-Ab ELISA and 
with a normal eosinophil count) and OLM, respectively. 
Other immunoassays showed a LOD of 78 ng/ml [17], 4 
ng/ml [27] and 5 ng/ml [16]. The most recent attempt to 
detect TES antigen in clinical samples reported a LOD of 
0.440 ng/ml [18]. These assays estimated the LOD by a 
standard curve constructed in PBS-Tween 20 as diluent. 
In contrast to the previously published studies on TES 
antigens detection, we used ‘negative’ serum spiked with 
TES and treated it with the ICD procedure before the 
TES detection, i.e. we applied exactly the same procedure 
as for the real samples to properly estimate the realistic 
LOD of the analysis. It rendered the LOD of 0.9 ng/ml 
and an average concentration of TES in positive samples 
of 2.1 ng/ml (SD = 1.1).
Active HT is associated with eosinophilia
Eosinophilia is a common feature in helminth infec-
tions [28]. For HT, Gillespie et  al. [26] reported eosino-
philia > 0.4 ×  109/l in 28 patients with VLM; of these, 19 
scored positive in TES antigen detection using a sand-
wich ELISA with the monoclonal Ab Tcn-2. In addi-
tion, the association between seropositivity (by TES-Ab 
ELISA) and eosinophilia has been extensively docu-
mented [1, 10, 13, 14, 29–33]. These data are in line with 
our findings. We found a significant association between 
eosinophilia > 19% of total WBC and a positive outcome 
by the electrochemical assay as well as by TES-Ab ELISA. 
Importantly, the samples used in the present study had 
eosinophilia > 19%, which is substantially higher than the 
traditional cut-off of 5% of total WBC count. Thus, very 
high eosinophilia could be a reliable, but non-specific, 
indicator of active HT. The usefulness of eosinophilia in 
the diagnosis of HT is limited since it is not a specific 
indicator of T. canis infection, and high levels of eosino-
phils can be found in other helminth infections, atopic 
and allergic diseases and adverse drug reactions [34].
Active T. canis infections are frequently diagnosed by 
the combination of a positive TES-Ab ELISA accompa-
nied by eosinophilia [35]. In contrast, the electrochemi-
cal assay can be used as a single parameter to identify 
active infections. In our study, we found that half of the 
Fig. 3 a Percentage of positives by electrochemistry in children with 
high (> 19%) and low (< 20%) eosinophilia. b Percentage of positives 
by Ab TES‑ELISA in children with high (> 19%) and low (< 20%) 
eosinophilia. Asterisks indicate significant association (P < 0.05)
Fig. 4 a Percentage of positives by electrochemistry in children with 
and without helminths (other than T. canis). b Percentage of positives 
by TES‑Ab ELISA in children with and without other helminth 
infections. No significant association was observed between the 
percentage of helminth‑positive and a positive outcome in either of 
the tests
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children with eosinophilia > 19% and positive by TES-Ab 
ELISA were also positive by the electrochemical assay. In 
contrast, only 11% of children with eosinophilia < 20% 
and positive by TES-Ab ELISA were positive by the elec-
trochemical assay. These findings illustrate an important 
limitation of a TES-Ab ELISA positive result combined 
with high eosinophilia as the criteria to diagnose HT, 
which is that positive TES-Ab ELISA in the presence of 
high eosinophilia can in general occur and cannot cer-
tainly indicate active infections.
No indication of cross‑reactivity with other helminth 
parasites
The detection of TES in serum by ELISA has been asso-
ciated with high cross-reactivity to other helminth para-
sites such as Ascaris lumbricoides, Trichinella spiralis, 
Schistosoma spp. and Fasciola hepatica [15, 26]. Cross-
reactivity with other parasites is a problem, particularly 
in rural settings where polyparasitism is frequent [10, 
36]. In our study, we did not find a significant association 
between positivity in the electrochemical assay and other 
STH infections. In fact, we found more helminth infec-
tions in children that scored negative by electrochemis-
try than in those that scored positive. This highlights the 
specificity of our test. The four children that had a posi-
tive outcome in the electrochemical test and were hel-
minth positive, most likely had mixed infections. Due to 
the difficulty of defining truly negative controls for HT 
in endemic areas with available diagnostic methods, the 
determination of the specificity of TES antigen detection 
is difficult. Moreover, the small sample size in the present 
study complicates a precise interpretation of the results.
A major issue on the diagnosis of HT by the TES Ab-
ELISA is the lack of specificity, particularly in countries 
where polyparasitism is prevalent. Western blot (WB) of 
serum against TES has been demonstrated to be more 
specific in combination with ELISA for the diagnosis 
of HT [37]. However, it requires equipment that is not 
always available in the field, and the procedure is more 
laborious, particularly for large sets of samples. While the 
latter aspect limits the application of WB for the diagno-
sis of HT, future studies should include this additional 
test, if conditions allow.
Conclusions
The electrochemical assay was able to identify active 
HT infections in a group of 87 children from remote 
communities in the province of Esmeraldas in Ecua-
dor. This is, to our knowledge, the most accurate quan-
tification of TES in human serum samples reported 
so far. As the electrochemical assay provides evidence 
for the presence of Toxocara larvae, it has the poten-
tial to become a powerful instrument for the diagnosis 
of active HT infections. Further validation of the assay 
with a larger number of clinically and epidemiologically 
well-defined samples is needed.
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